Autologous bone marrow transplantation for multiple myeloma

ArticleinHematology/Oncology Clinics of North America 6(2):437-49 · May 1992
Impact Factor: 2.30 · Source: PubMed

    Abstract

    Intensive cytotoxic chemotherapy is capable of more marked tumor cytoreduction including true complete remissions in multiple myeloma. Use of autologous marrow and blood stem cells as well as growth factors has reduced the risk of infection and severe extramedullary toxicities.